Skip to main content
Caplight Logo









Bonac Corporation

Bonac Corporation

Private
KurumeHealthcare & Life Scienceshttps://bonac.co.jp

Last Round

Grant

Apr 1, 2021

Total Funding Raised

$85.78M

Company Overview

Bonac Corporation is a biotechnology company that researches and develops nucleic acid medicines using proprietary oligonucleotide chemistry technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nucleic acid medicinedrug discoveryoligonucleotide chemistrynkRNAPnkRNAbiotechRNA therapeuticsdrug licensingnuclease degradationbiotech startuptherapeutic platformRNA interferencebiopharmadrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bonac Corporation Comparables

Compare Bonac Corporation with similar companies based on industry and business-model similarity.

Bonac Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Luxna Biotech Co., Ltd.
77%
ANRis, Inc.
77%
TAGCyx Biotechnologies Inc.
77%

Bonac Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2021
Corporate FundingDec 1, 2020
Private EquitySep 25, 2017
VC RoundJul 4, 2016
VC RoundJan 6, 2016
Corporate Funding
Dec 1, 2015

Bonac Corporation Investors

Notable investors and investment history

Bonac Corporation investors
InvestorRounds
Japan Agency for Medical Research and DevelopmentGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2020

    $280K raised from Fukuoka Prefectural Government.

  • Jul 4, 2016

    Sumitomo Chemical participated in the round.

Bonac Corporation Filings

Explore SEC and related filing metadata, where available.

Bonac Corporation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bonac Corporation's valuation, stock price, and market status.

Is Bonac Corporation a public or private company?

Bonac Corporation is a private company.

What is the current stock price of Bonac Corporation?

Bonac Corporation is a private company with no public stock price. No recent secondary market data is available.

How much is Bonac Corporation worth (valuation)?

Valuation information for Bonac Corporation is not publicly available.

Can I buy Bonac Corporation stock?

Bonac Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bonac Corporation's last funding round?

Bonac Corporation's most recent funding round was Grant on April 1, 2021.

Who are the main investors in Bonac Corporation?

Key investors in Bonac Corporation include Japan Agency for Medical Research and Development.

Will Bonac Corporation IPO soon?

No public IPO plans have been announced for Bonac Corporation.

How can I track Bonac Corporation secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bonac Corporation's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKurume
Year Founded2010
Last FundingApr 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?